Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature ReviewInternational journal of chronic obstructive pulmonary disease, , Vol.15, p.439-460 [Peer Reviewed Journal]2020 Iheanacho et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Iheanacho et al. 2020 Iheanacho et al. ;ISSN: 1178-2005 ;ISSN: 1176-9106 ;EISSN: 1178-2005 ;DOI: 10.2147/copd.s234942 ;PMID: 32161455Full text available |
2 |
Material Type: Article
|
![]() |
Impact of Single Combination Inhaler versus Multiple Inhalers to Deliver the Same Medications for Patients with Asthma or COPD: A Systematic Literature ReviewInternational journal of chronic obstructive pulmonary disease, 2020-02, Vol.15, p.417-438 [Peer Reviewed Journal]2020 Zhang et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Zhang et al. 2020 Zhang et al. ;ISSN: 1178-2005 ;ISSN: 1176-9106 ;EISSN: 1178-2005 ;DOI: 10.2147/COPD.S234823 ;PMID: 32161454Full text available |
3 |
Material Type: Article
|
![]() |
Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UKInternational journal of chronic obstructive pulmonary disease, 2023-11, Vol.18, p.2673-2685 [Peer Reviewed Journal]COPYRIGHT 2023 Dove Medical Press Limited ;ISSN: 1178-2005 ;EISSN: 1178-2005 ;DOI: 10.2147/COPD.S413947Full text available |
4 |
Material Type: Article
|
![]() |
Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β 2 -Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in EnglandInternational journal of chronic obstructive pulmonary disease, 2023, Vol.18, p.231 [Peer Reviewed Journal]2023 Requena et al. ;EISSN: 1178-2005 ;DOI: 10.2147/COPD.S389281 ;PMID: 36908830Full text available |
5 |
Material Type: Article
|
![]() |
Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort studyRespiratory research, 2023-09, Vol.24 (1), p.229-229, Article 229 [Peer Reviewed Journal]2023. BioMed Central Ltd., part of Springer Nature. ;COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1465-993X ;ISSN: 1465-9921 ;EISSN: 1465-993X ;DOI: 10.1186/s12931-023-02523-1 ;PMID: 37749551Full text available |
6 |
Material Type: Article
|
![]() |
Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort studyRespiratory research, 2024-04, Vol.25 (1), p.152-152 [Peer Reviewed Journal]COPYRIGHT 2024 BioMed Central Ltd. ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;ISSN: 1465-9921 ;ISSN: 1465-993X ;EISSN: 1465-993X ;DOI: 10.1186/s12931-024-02745-x ;PMID: 38561735Full text available |
7 |
Material Type: Article
|
![]() |
DElaying Disease Progression In COPD with Early Initiation of Dual Bronchodilator or Triple Inhaled PharmacoTherapy (DEPICT): A Predictive Modelling ApproachAdvances in therapy, 2023-10, Vol.40 (10), p.4282-4297 [Peer Reviewed Journal]The Author(s) 2023. corrected publication 2023 ;ISSN: 0741-238X ;EISSN: 1865-8652 ;DOI: 10.1007/s12325-023-02583-1Digital Resources/Online E-Resources |
8 |
Material Type: Article
|
![]() |
Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B2-agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort studyBMJ open, 2024-02, Vol.14 (2), p.e072361 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2024 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2023-072361 ;PMID: 38326272Full text available |
9 |
Material Type: Article
|
![]() |
Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in EnglandInternational journal of chronic obstructive pulmonary disease, 2023-01, Vol.18, p.1431-1444 [Peer Reviewed Journal]2023 Requena et al. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023 Requena et al. 2023 Requena et al. ;ISSN: 1178-2005 ;ISSN: 1176-9106 ;EISSN: 1178-2005 ;DOI: 10.2147/COPD.S411437 ;PMID: 37465818Full text available |
10 |
Material Type: Article
|
![]() |
Correction to: DElaying Disease Progression In COPD with Early Initiation of Dual Bronchodilator or Triple Inhaled PharmacoTherapy (DEPICT): A Predictive Modelling ApproachAdvances in therapy, 2023-10, Vol.40 (10), p.4689-4690 [Peer Reviewed Journal]Springer Healthcare Ltd., part of Springer Nature 2023 ;ISSN: 0741-238X ;EISSN: 1865-8652 ;DOI: 10.1007/s12325-023-02613-yDigital Resources/Online E-Resources |
11 |
Material Type: Article
|
![]() |
INTREPID: single- versus multiple-inhaler triple therapy for COPD in usual clinical practiceERJ open research, 2021-04, Vol.7 (2), p.950 [Peer Reviewed Journal]Copyright ©The authors 2021. ;Copyright ©The authors 2021 2021 ;ISSN: 2312-0541 ;EISSN: 2312-0541 ;DOI: 10.1183/23120541.00950-2020 ;PMID: 34109236Full text available |
12 |
Material Type: Article
|
![]() |
Burden of Disease in Patients with Mild or Mild-to-Moderate Chronic Obstructive Pulmonary Disease (Global Initiative for Chronic Obstructive Lung Disease Group A or B): A Systematic Literature ReviewInternational journal of chronic obstructive pulmonary disease, 2023-05, Vol.18, p.719-731 [Peer Reviewed Journal]2023 Czira et al. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023 Czira et al. 2023 Czira et al. ;ISSN: 1178-2005 ;ISSN: 1176-9106 ;EISSN: 1178-2005 ;DOI: 10.2147/COPD.S394325 ;PMID: 37151760Full text available |
13 |
Material Type: Article
|
![]() |
Benefit of Prompt Vs Delayed Initiation of Triple Therapy Following an Exacerbation in Patients with COPD in Japan: A Retrospective Cohort StudyInternational journal of chronic obstructive pulmonary disease, 2023-01, Vol.18, p.2933-2953 [Peer Reviewed Journal]2023 Czira et al. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023 Czira et al. 2023 Czira et al. ;ISSN: 1178-2005 ;ISSN: 1176-9106 ;EISSN: 1178-2005 ;DOI: 10.2147/COPD.S419119 ;PMID: 38089540Full text available |
14 |
Material Type: Article
|
![]() |
Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-AnalysisAdvances in therapy, 2022-09, Vol.39 (9), p.3957-3978 [Peer Reviewed Journal]The Author(s) 2022 ;ISSN: 0741-238X ;EISSN: 1865-8652 ;DOI: 10.1007/s12325-022-02231-0Digital Resources/Online E-Resources |
15 |
Material Type: Article
|
![]() |
Correction to: A tutorial on pilot studies: the what, why and howBMC medical research methodology, 2023-03, Vol.23 (1), p.59-59, Article 59 [Peer Reviewed Journal]COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1471-2288 ;EISSN: 1471-2288 ;DOI: 10.1186/s12874-023-01880-1 ;PMID: 36927764Full text available |
16 |
Material Type: Article
|
![]() |
Cost-effectiveness analysis of a single-inhaler triple therapy for COPD in the UKERJ open research, 2021-01, Vol.7 (1), p.480 [Peer Reviewed Journal]Copyright ©ERS 2021. ;Copyright ©ERS 2021 2021 ;ISSN: 2312-0541 ;EISSN: 2312-0541 ;DOI: 10.1183/23120541.00480-2020 ;PMID: 33778055Full text available |
17 |
Material Type: Article
|
![]() |
Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-AnalysisAdvances in therapy, 2022-11, Vol.39 (11), p.4961-5010 [Peer Reviewed Journal]The Author(s) 2022. corrected publication 2022 ;ISSN: 0741-238X ;EISSN: 1865-8652 ;DOI: 10.1007/s12325-022-02234-xDigital Resources/Online E-Resources |
18 |
Material Type: Article
|
![]() |
Cost-Effectiveness of Single-Inhaler Triple Therapy (FF/UMEC/VI) versus Tiotropium Monotherapy in Patients with Symptomatic Moderate-to-Very Severe COPD in the UKInternational journal of chronic obstructive pulmonary disease, 2023-01, Vol.18, p.1815-1825 [Peer Reviewed Journal]COPYRIGHT 2023 Dove Medical Press Limited ;2023 Kendall et al. 2023 Kendall et al. ;ISSN: 1178-2005 ;ISSN: 1176-9106 ;EISSN: 1178-2005 ;DOI: 10.2147/COPD.S400707Full text available |
19 |
Material Type: Article
|
![]() |
Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in GermanyInternational journal of chronic obstructive pulmonary disease, 2024-01, Vol.19, p.945-956 [Peer Reviewed Journal]2024 Beeh et al. ;COPYRIGHT 2024 Dove Medical Press Limited ;2024 Beeh et al. 2024 Beeh et al. ;ISSN: 1178-2005 ;ISSN: 1176-9106 ;EISSN: 1178-2005 ;DOI: 10.2147/COPD.S431291 ;PMID: 38646606Full text available |
20 |
Material Type: Article
|
![]() |
A Response to: Letter to the Editor Regarding “Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-analysis”Advances in therapy, 2023-05, Vol.40 (5), p.2556-2561 [Peer Reviewed Journal]The Author(s) 2023 ;ISSN: 0741-238X ;EISSN: 1865-8652 ;DOI: 10.1007/s12325-023-02495-0Digital Resources/Online E-Resources |